Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma (Q83130692)
Jump to navigation
Jump to search
scientific article published on 23 December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma |
scientific article published on 23 December 2011 |
Statements
Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma (English)
Kazushi Numata
Hiroyuki Fukuda
Manabu Morimoto
Masaaki Kondo
Akito Nozaki
Takashi Oshima
Masahiro Okada
Shigeo Takebayashi
Shin Maeda
Katsuaki Tanaka
23 December 2011